水產養殖疫苗市場規模、佔有率和成長分析（按產品、給藥途徑、應用和地區分類）—產業預測，2026-2033年

預計到 2024 年，全球水產養殖疫苗市場規模將達到 2.3091 億美元，從 2025 年的 2.4846 億美元成長到 2033 年的 4.4643 億美元，在預測期（2026-2033 年）內複合年成長率為 7.6%。

養殖物種細菌和病毒性行為感染的增加迫使生產者採取疫苗接種策略，推動了全球水產養殖疫苗市場的顯著成長。針對各種病毒性疾病的創新疫苗的研發和推廣對於提升市場收入至關重要。隨著產業的演變，疫苗類型已從傳統的活病毒疫苗顯著轉向DNA疫苗和重組疫苗。對新型疫苗研發投入的不斷增加也推動了這一成長。此外，水產養殖產量的成長和消費者對水產品日益成長的需求進一步刺激了對有效疫苗解決方案的需求。水產養殖業和更廣泛的動物健康領域的許多主要企業正在重新分配資源以滿足這些關鍵需求，這充分體現了該市場的活力。

全球水產養殖疫苗市場促進因素

由於各種疾病爆發導致魚類死亡率上升，全球水產養殖疫苗市場呈現成長態勢，迫切需要有效的疫苗解決方案。全球對魚類作為動物性蛋白質來源的需求不斷成長，以及各國政府對水產養殖疫苗舉措的大力支持，進一步推動了這個市場擴張。此外，成熟市場和新興市場對疫苗的日益普及預計也將推動市場動態。養殖魚類國際貿易的不斷成長也將對市場發展起到關鍵作用，使水產養殖疫苗成為全球永續水產養殖實踐不可或缺的一部分。

限制全球水產養殖疫苗市場的因素

開發符合嚴格環境和監管標準的具成本效益佐劑和抗原，會對水產養殖疫苗的市場動態重大影響。遵守這些基本準則通常會增加生產成本和複雜性，最終阻礙該行業的疫苗銷售。因此，製造商被迫在確保產品功效和滿足合規要求之間尋求平衡，而這項挑戰可能會限制水產養殖疫苗的市場佔有率。這些因素綜合起來，可能會阻礙產業成長，並影響水產養殖疫苗市場的供給與需求雙方。

全球水產養殖疫苗市場趨勢

由於技術進步、人們對水產養殖疾病的認知不斷提高以及公私合營在研發領域的加強，全球水產養殖疫苗市場正呈現顯著的成長趨勢。診斷和治療技術的創新，尤其是在發展中地區，以及醫療費用支出的不斷成長，預計將推動市場成長。此外，產業內策略聯盟和合作的日益增多，以及對通用感染疾病的日益關注，也進一步刺激了對水產養殖疫苗的需求。這些因素共同推動了整體市場成長，為食品生產產業這一關鍵領域的持續成長鋪平了道路。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究

全球水產養殖疫苗市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 減毒活病毒疫苗
• 去活化疫苗
• 次單位疫苗
• DNA疫苗
• 重組疫苗

全球水產養殖疫苗市場規模（按給藥途徑和複合年成長率分類）（2026-2033 年）

• 口服
• 注射
• 浸泡/噴灑

全球水產養殖疫苗市場規模（按應用和複合年成長率分類）（2026-2033 年）

• 細菌
• 病毒性的
• 寄生蟲
• 其他

全球水產養殖疫苗市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Elanco Animal Health（USA）
• Hipra（Spain）
• Ceva Sante Animale（France）
• Vaxxinova（Netherlands）
• AquaBounty Technologies（USA）
• Benchmark Holdings plc（UK）
• Pharmaq AS（Norway）
• Phibro Animal Health Corporation（USA）
• KBNP（South Korea）
• Nisseiken Co., Ltd.（Japan）
• Kyoto Biken Laboratories, Inc.（Japan）
• Cavac（China）
• VETERQUIMICA SA（Spain）
• CSL Limited（Australia）
• Emergent BioSolutions, Inc.（USA）
• Johnson & Johnson（USA）
• AstraZeneca plc（UK）
• Sanofi SA（France）

結論與建議

Global Aquaculture Vaccine Market size was valued at USD 230.91 Million in 2024 and is poised to grow from USD 248.46 Million in 2025 to USD 446.43 Million by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global aquaculture vaccine market is poised for significant growth driven by escalating bacterial and viral infections among aquaculture species, compelling producers to adopt vaccination strategies. The development and introduction of innovative vaccines targeting various viral diseases are crucial for enhancing market revenue. A notable shift is occurring, moving from traditional live attenuated vaccines towards DNA and recombinant vaccines, reflecting industry evolution. Increased investment in research and development of novel vaccines further supports this expansion. Additionally, rising aquaculture production and a growing consumer preference for seafood products heighten the demand for effective vaccination solutions. Numerous key players from both aquaculture and broader animal health sectors are reallocating resources to meet these essential needs, showcasing the dynamic nature of this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aquaculture Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aquaculture Vaccine Market Segments Analysis

Global Aquaculture Vaccine Market is segmented by Product, Route of Administration, Application and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Oral, Injected and Immersion & Spray. Based on Application, the market is segmented into Bacterial, Viral, Parasitic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is poised for growth due to rising fish mortality rates attributed to various disease outbreaks, which create an urgent demand for effective vaccination solutions. The increasing global appetite for fish as a source of animal protein, coupled with substantial government backing for vaccination initiatives in aquaculture, further fuels this expansion. Additionally, a rising adoption of vaccines in both established and emerging markets is expected to enhance market dynamics. Increased international trade of aquaculture species will also play a crucial role in driving market advancements, positioning aquaculture vaccines as essential in sustainable fish farming practices worldwide.

Restraints in the Global Aquaculture Vaccine Market

The development of cost-effective adjuvants and antigens that comply with stringent environmental and regulatory standards can significantly influence the market dynamics of aquaculture vaccines. This adherence to necessary guidelines often leads to increased production costs and complexities, ultimately hindering vaccination sales within the sector. Consequently, these challenges may restrict the market share for aquaculture vaccines, as manufacturers must navigate the balance between ensuring product efficacy and meeting compliance demands. The combination of these factors can create obstacles for industry growth, impacting both supply and demand in the aquaculture vaccine market.

Market Trends of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is experiencing a significant upward trend driven by advancements in technology, heightened awareness of aquaculture diseases, and increased public-private partnerships aimed at research and development. Innovations in diagnostics and therapeutics, particularly in developing regions, alongside rising healthcare expenditure, are poised to propel market growth. Moreover, the proliferation of strategic alliances and collaborations within the industry, combined with the escalating concerns over zoonotic diseases, further amplify the demand for aquaculture vaccines. The overall market is expected to thrive as these factors converge, paving the way for sustained growth in this vital sector of the food production industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Aquaculture Vaccine Market Size by Product & CAGR (2026-2033)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Aquaculture Vaccine Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injected
• Immersion & Spray

Global Aquaculture Vaccine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bacterial
• Viral
• Parasitic
• Others

Global Aquaculture Vaccine Market Size & CAGR (2026-2033)

• North America (Product, Route of Administration, Application)
  • US
  • Canada
• Europe (Product, Route of Administration, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AquaBounty Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchmark Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaq AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBNP (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nisseiken Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Biken Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cavac (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VETERQUIMICA SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations